OSCR
Oscar Health, Inc.
NYSE · Healthcare · Medical - Healthcare Plans · US
$32.13
+0.47%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.15
- Revenue estimate
- $4.7B
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $1.10
- EPS estimate
- $0.40
- Revenue actual
- $4.8B
- Revenue estimate
- $4.7B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +62.2%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $34
- PT range
- $26 – $49
- Analysts
- 7
2 Buy4 Hold1 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.40 | $1.10 | Beat 172.95% | $4.8B |
| May 6, 2026 | $1.21 | $2.07 | Beat 71.07% | $4.6B |
| Nov 6, 2025 | -$0.55 | -$0.53 | Beat 3.64% | $3.0B |
| Aug 6, 2025 | -$0.90 | -$0.89 | Beat 1.11% | $2.9B |
| Feb 4, 2025 | -$0.55 | -$0.62 | Miss -12.73% | $2.4B |
| Nov 7, 2024 | -$0.20 | -$0.22 | Miss -10.00% | $2.4B |
| Feb 7, 2024 | -$0.74 | -$0.66 | Beat 10.81% | $1.4B |
| Feb 9, 2023 | -$1.01 | -$1.05 | Miss -3.96% | $1.0B |
| Aug 11, 2022 | -$0.73 | -$0.53 | Beat 27.40% | $1.1B |
| Feb 10, 2022 | -$1.03 | -$0.95 | Beat 7.77% | $520.3M |
| Nov 10, 2021 | -$0.68 | -$1.02 | Miss -50.00% | $462.2M |
| Aug 12, 2021 | -$0.47 | -$0.35 | Beat 25.53% | $549.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026